
About Us
Almirall was founded in Barcelona, Spain, in 1943, and now operates in 21 countries through 13 affiliates with a portfolio of 40 products marketed across various geographies. A family company, we are focused on medical dermatology and skin health. Our US organization was acquired by Almirall S.A.
Our Expertise
We invest heavily in R&D with nearly 14% of sales revenue and employees devoted to achieving our goal of being a leader of innovation in medical dermatology. Almirall strives every day to turn our expertise into real solutions.
What is PAP in Boehringer Ingelheim?from boehringer-ingelheim.us
The PAP is one of the four core programs of Boehringer Ingelheim Cares Foundation.
What is a PAP?from boehringer-ingelheim.us
The PAP is one of the four core programs of Boehringer Ingelheim Cares Foundation. The other programs include the Product Donation Program, Financial Contributions Program, and Employee Volunteer Program. Through these programs, Boehringer Ingelheim provides more health in local U.S. communities and around the world. About Boehringer Ingelheim.
Does Boehringer Ingelheim Cares offer Medicare?from patientassistance.com
Boehringer Ingelheim CARES Foundation Patient Assistance Program For Medicare Beneficiaries, a patient assistance program provided by Boehringer Ingelheim Pharmaceuticals, Inc., offers the medications listed to the right at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
How old do you have to be to get a Humira?from abbvie.com
Our online application is for use by people over the age of eighteen and seeking assistance (the patient) for either HUMIRA® (adalimumab) or SKYRIZITM (rizankizumab-rzaa). We will ask you to register and complete an application. Before you start, please make sure that you have electronic copies of the necessary documents, listed further below.
Who offers myAbbVie Assist?from abbvie.com
myAbbVie Assist is offered by AbbVie Inc. and the AbbVie Patient Assistance Foundation, a separate legal entity from AbbVie Inc.
